C0686217||Carcinoma In Situ of the Glans Penis
C0392251||Carbon Dioxide Laser
C0728940||Excision
C0686217||carcinoma in situ (CIS) of the glans penis
C0154089||erythroplasia of Queyrat
C1519552||topical chemotherapy
C0021083||immunotherapy
C0728940||surgical excision
C0728940||evaluated
C0392251||carbon dioxide laser
C0348007||ablation
C0221198||lesion
C0686217||carcinoma in situ
C0332293||treated
C0392251||carbon dioxide laser
C0348007||ablation
C0019637||histologic examination
C0013221||toxicity
C0879626||adverse effects
C0019637||histologic examination
C0332652||no residual tumor
C4050307||complete response
C4050307||complete response
C0677946||stable disease
C1335499||progressive disease
C4050307||complete response
C0021344||human papillomavirus
C0221198||lesions
C1513916||no
C1522577||follow-up
C1335499||progressive disease
C0194708||penectomy
C2584946||alive
C0260832||follow-up examination
C0013221||toxicity
C0085624||burning erythema
C1513916||no
C0879626||adverse effects
C0686217||carcinoma in situ
C0021344||human papillomavirus
C0221198||lesions
C0019637||histologic examination
C0012634||disease
C1522577||follow-up
C0442711||protocol